Healthcare provider profile · identity verified

Michael C Maroon, D.O.

Family Practice · MORGANTOWN, WV · NPI 1396857819

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	532	105
Lisinopril	Lisinopril	505	115
Omeprazole	Omeprazole	440	79
Metoprolol Succinate	Metoprolol Succinate	298	66
Amlodipine Besylate	Amlodipine Besylate	296	70
Famotidine	Famotidine	239	39
Levothyroxine Sodium	Levothyroxine Sodium	222	47
Pantoprazole Sodium	Pantoprazole Sodium	222	43
Tamsulosin Hcl	Tamsulosin Hcl	221	46
Metformin Hcl Er	Metformin Hcl	217	40
Gabapentin	Gabapentin	208	41
Hydrochlorothiazide	Hydrochlorothiazide	201	51
Losartan Potassium	Losartan Potassium	197	45
Rosuvastatin Calcium	Rosuvastatin Calcium	186	50
Tramadol Hcl	Tramadol Hcl	147	18
Metoprolol Tartrate	Metoprolol Tartrate	126	23
Trazodone Hcl	Trazodone Hcl	124	28
Albuterol Sulfate Hfa	Albuterol Sulfate	116	40
Furosemide	Furosemide	114	26
Montelukast Sodium	Montelukast Sodium	106	30
Simvastatin	Simvastatin	106	24
Metformin Hcl	Metformin Hcl	102	22
Sertraline Hcl	Sertraline Hcl	102	25
Fluticasone Propionate	Fluticasone Propionate	98	25
Diclofenac Sodium	Diclofenac Sodium	91	21
Tizanidine Hcl	Tizanidine Hcl	88	29
Duloxetine Hcl	Duloxetine Hcl	87	20
Ozempic	Semaglutide	85	16
Glipizide Er	Glipizide	79	15
Allopurinol	Allopurinol	72	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	69	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	68	15
Pravastatin Sodium	Pravastatin Sodium	64	14
Alendronate Sodium	Alendronate Sodium	59	14
Escitalopram Oxalate	Escitalopram Oxalate	59	13
Buspirone Hcl	Buspirone Hcl	58	14
Eliquis	Apixaban	58	15
Ropinirole Hcl	Ropinirole Hcl	58	12
Clopidogrel	Clopidogrel Bisulfate	54	11
Ventolin Hfa	Albuterol Sulfate	54	14
Jardiance	Empagliflozin	53	17
Ibuprofen	Ibuprofen	52	13
Ezetimibe	Ezetimibe	51	suppressed
Potassium Chloride	Potassium Chloride	49	12
Spironolactone	Spironolactone	47	suppressed
Trulicity	Dulaglutide	43	suppressed
Ondansetron Hcl	Ondansetron Hcl	42	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	42	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	41	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	11
Carvedilol	Carvedilol	40	14
Pregabalin	Pregabalin	40	suppressed
Atenolol	Atenolol	39	suppressed
Glycopyrrolate	Glycopyrrolate	39	suppressed
Finasteride	Finasteride	38	suppressed
Bupropion Xl	Bupropion Hcl	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	suppressed
Nifedipine Er	Nifedipine	33	suppressed
Prednisone	Prednisone	33	20
Propranolol Hcl Er	Propranolol Hcl	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Clonidine Hcl	Clonidine Hcl	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	18
Lantus	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Lovastatin	Lovastatin	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Meloxicam	Meloxicam	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Vascepa	Icosapent Ethyl	24	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Clonazepam	Clonazepam	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Nystatin	Nystatin	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Naproxen	Naproxen	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Topiramate	Topiramate	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Dutasteride	Dutasteride	17	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Felodipine Er	Felodipine	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Baclofen	Baclofen	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Colchicine	Colchicine	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Chlorzoxazone	Chlorzoxazone	12	suppressed
Digoxin	Digoxin	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Mexiletine Hcl	Mexiletine Hcl	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Linzess	Linaclotide	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Naltrexone Hcl	Naltrexone Hcl	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error